Publication | Closed Access

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia

Regenerative MedicineCell TherapyMedicineInterim Analysis ResultsHematologyCritical Limb IschemiaLimb RestorationStrokeCell TransplantationOrthopaedic SurgeryIschemic SyndromeReperfusion Injury